NGD vs. CRVS

Last updated Jun 13, 2026

NGD (New Gold Inc.) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. NGD operates in Gold (Basic Materials), while CRVS operates in Biotechnology (Healthcare). At a 0.09 correlation, their price movements are largely independent.

Performance

NGD vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in New Gold Inc. (NGD) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

NGD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CRVS

• 1D: 2.84%
• 1M: -24.68%
• YTD: 54.94%
• 6M: 42.53%
• 1Y: 181.37%
• 3Y*: 53.32%
• 5Y*: 33.63%
• 10Y*: 0.06%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NGD vs. CRVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NGD New Gold Inc.	4.25%	251.21%	69.86%	48.98%	-34.67%	-31.51%	148.86%	16.28%	-77.00%	-6.00%
CRVS Corvus Pharmaceuticals, Inc.	54.94%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	48.23%	-64.58%	-27.55%

Correlation

The correlation between NGD and CRVS is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (10Y) Calculated over the trailing 10-year period	0.09
Correlation (All Time) Calculated using the full available price history since Mar 23, 2016	0.09

Fundamentals

EPS NGD : $1.61 CRVS : -$0.53
Total Revenue (TTM) NGD : $1.46B CRVS : $0.00
Gross Profit (TTM) NGD : $758.26M CRVS : -$26.00K
EBITDA (TTM) NGD : $1.19B CRVS : -$47.43M

Return for Risk

NGD vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NGD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

CRVS

CRVS Risk / Return Rank: 86
CRVS Sharpe Ratio Rank: 73
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 85
CRVS Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NGD vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for New Gold Inc. (NGD) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NGD	CRVS	Difference
Sharpe ratio: Return per unit of total volatility	—	1.01	—
Sortino ratio: Return per unit of downside risk	—	4.24	—
Omega ratio: Gain probability vs. loss probability	—	1.48	—
Calmar ratio: Return relative to maximum drawdown	—	3.23	—
Martin ratio: Return relative to average drawdown	—	7.03	—

Drawdowns

Drawdown Indicators

	NGD	CRVS	Difference
Max Drawdown Largest peak-to-trough decline	—	-96.97%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-56.43%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-70.50%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-92.40%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-96.97%	—
Current Drawdown Current decline from peak	—	-53.25%	—
Average Drawdown Average peak-to-trough decline	—	-69.28%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	25.91%	—

Volatility

Volatility by Period

	NGD	CRVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	23.12%	—
Volatility (6M) Calculated over the trailing 6-month period	—	111.88%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	180.64%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	131.02%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	111.13%	—

Dividends

NGD vs. CRVS - Dividend Comparison

Neither NGD nor CRVS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both NGD and CRVS in my portfolio?

NGD and CRVS have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.